Tumor treating fields (TTFields): A novel treatment modality added to standard chemo- and radiotherapy in newly diagnosed glioblastoma—First report of the full dataset of the EF14 randomized phase III trial.

• Stupp, Roger University Hospital Zurich & University of Zurich, Zurich, Switzerland
• Taillibert, Sophie Hopital Pitie-Salpetriere, Paris, France
• Kanner, Andrew Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
• Kesari, Santosh UC San Diego, La Jolla, CA
• Toms, Steven A Geisinger Health System, Danville, PA
• Barnett, Gene H. Cleveland Clinic Foundation, Cleveland, OH
• Fink, Karen L. Baylor Research Institute, Dallas, TX
• Silvani, Antonio Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
• Lieberman, Frank S. University of Pittsburgh, Pittsburgh, PA
• Zhu, Jay-Jiguang The University of Texas Medical School at Houston, Houston, TX
• Taylor, Lynne Patricia Tufts Medical Center, Boston, MA
• Honnorat, Jerôme Hopital Pierre Wertheimer, Lyon, France
• Hottinger, Andreas Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
• Chen, Thomas University of Southern California, Los Angeles, CA
• Tran, David Dinh Washington University, St Louis, MO
• Kim, Chae-yong Seoul Natl Univ Bundang Hosp, Seongnam-si, Korea South
• Hirte, Hal W. Juravinski Cancer Centre, Hamilton, ON, Canada
• Hegi, Monika E. University of Lausanne Hospitals, Lausanne, Switzerland
• Palti, Yoram Novocure, Haifa, Israel
• Ram, Zvi Tel Aviv University, Tel Aviv, Israel

Cancer Research

Oncology